Cargando…
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
Parkinson’s Disease (PD) is currently the most rapid growing neurodegenerative disease and over the past generation, its global burden has more than doubled. The onset of PD can arise due to environmental, sporadic or genetic factors. Nevertheless, most PD cases have an unknown etiology. Chemicals,...
Autores principales: | Ferreira, Carla, Almeida, Catarina, Tenreiro, Sandra, Quintas, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344445/ https://www.ncbi.nlm.nih.gov/pubmed/32545328 http://dx.doi.org/10.3390/life10060086 |
Ejemplares similares
-
A biophysical perspective on the unexplored mechanisms driving Parkinson’s disease by amphetamine-like stimulants
por: Ferreira, Carla, et al.
Publicado: (2021) -
Developmental neurotoxicity induced by therapeutic and illicit drugs.
por: Vorhees, C V
Publicado: (1994) -
Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017) -
Salsolinol—neurotoxic or Neuroprotective?
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2019) -
Ketamine: Neuroprotective or Neurotoxic?
por: Choudhury, Divya, et al.
Publicado: (2021)